Amedisys PE Ratio 2010-2024 | AMED

Current and historical p/e ratio for Amedisys (AMED) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Amedisys PE ratio as of July 24, 2024 is 22.63.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Amedisys PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-07-24 97.58 0.00
2024-03-31 92.16 $-0.64 0.00
2023-12-31 95.06 $-0.31 0.00
2023-09-30 93.40 $0.07 1334.29
2023-06-30 91.44 $0.07 1306.29
2023-03-31 73.55 $3.44 21.38
2022-12-31 83.54 $3.64 22.95
2022-09-30 96.79 $3.71 26.09
2022-06-30 105.12 $4.29 24.50
2022-03-31 172.29 $5.81 29.65
2021-12-31 161.88 $6.34 25.53
2021-09-30 149.10 $6.66 22.39
2021-06-30 244.93 $7.45 32.88
2021-03-31 264.79 $6.06 43.69
2020-12-31 293.33 $5.52 53.14
2020-09-30 236.43 $4.99 47.38
2020-06-30 198.54 $3.86 51.44
2020-03-31 183.54 $3.84 47.80
2019-12-31 166.92 $3.83 43.58
2019-09-30 131.01 $3.84 34.12
2019-06-30 121.41 $3.77 32.20
2019-03-31 123.26 $3.73 33.05
2018-12-31 117.11 $3.57 32.80
2018-09-30 124.96 $2.62 47.69
2018-06-30 85.46 $2.08 41.09
2018-03-31 60.34 $1.23 49.06
2017-12-31 52.71 $0.88 59.90
2017-09-30 55.96 $1.25 44.77
2017-06-30 62.81 $1.17 53.68
2017-03-31 51.09 $1.36 37.57
2016-12-31 42.63 $1.11 38.41
2016-09-30 47.44 $1.23 38.57
2016-06-30 50.48 $1.14 44.28
2016-03-31 48.34 $1.14 42.40
2015-12-31 39.32 $-0.12 0.00
2015-09-30 37.97 $-0.22 0.00
2015-06-30 39.73 $-0.21 0.00
2015-03-31 26.78 $-0.30 0.00
2014-12-31 29.35 $0.38 77.24
2014-09-30 20.17 $-0.20 0.00
2014-06-30 16.74 $-3.35 0.00
2014-03-31 14.89 $-3.52 0.00
2013-12-31 14.63 $-3.04 0.00
2013-09-30 17.21 $-6.26 0.00
2013-06-30 11.60 $-3.04 0.00
2013-03-31 11.12 $-2.84 0.00
2012-12-31 11.31 $-2.78 0.00
2012-09-30 13.82 $-13.99 0.00
2012-06-30 12.45 $-13.57 0.00
2011-12-31 10.91 $-13.30 0.00
2011-09-30 14.82 $-12.68 0.00
2011-06-30 26.63 $2.23 11.94
2011-03-31 35.00 $2.24 15.63
2010-12-31 33.50 $2.84 11.80
2012-03-31 14.46 $3.36 4.30
2010-09-30 23.80 $4.53 5.25
2010-06-30 43.98 $5.06 8.69
2010-03-31 55.22 $5.20 10.62
2009-12-31 48.60 $4.90 9.92
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.194B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.078B 11.54
Quest Diagnostics (DGX) United States $15.659B 16.09
DaVita (DVA) United States $12.441B 15.45
Encompass Health (EHC) United States $8.734B 22.36
Chemed (CHE) United States $8.195B 25.40
Elanco Animal Health (ELAN) United States $6.553B 17.00
Option Care Health (OPCH) United States $5.453B 20.64
RadNet (RDNT) United States $4.806B 100.08
Astrana Health (ASTH) United States $2.869B 38.81
Addus HomeCare (ADUS) United States $2.193B 28.38
LifeStance Health (LFST) United States $2.129B 0.00
U.S Physical Therapy (USPH) United States $1.460B 39.08
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Pennant (PNTG) United States $0.873B 46.13
Atai Life Sciences (ATAI) Germany $0.263B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.027B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.013B 0.00
Ontrak (OTRK) United States $0.013B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00